Mint SA
PAR:ALBUD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mint SA
PAR:ALBUD
|
FR |
|
V
|
Vifor Pharma AG
SIX:VIFN
|
CH |
|
Ambea AB (publ)
STO:AMBEA
|
SE |
|
Tian Ruixiang Holdings Ltd
NASDAQ:TIRX
|
CN |
Balance Sheet
Balance Sheet Decomposition
Mint SA
Mint SA
Balance Sheet
Mint SA
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
12
|
11
|
3
|
1
|
1
|
6
|
7
|
11
|
22
|
24
|
|
| Cash |
12
|
11
|
3
|
1
|
1
|
6
|
7
|
11
|
22
|
24
|
|
| Total Receivables |
2
|
1
|
2
|
1
|
1
|
2
|
5
|
8
|
27
|
34
|
|
| Accounts Receivables |
2
|
1
|
1
|
1
|
1
|
1
|
3
|
6
|
21
|
29
|
|
| Other Receivables |
0
|
0
|
1
|
1
|
0
|
1
|
2
|
3
|
6
|
5
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
6
|
|
| Total Current Assets |
14
|
13
|
5
|
2
|
2
|
8
|
12
|
20
|
50
|
64
|
|
| PP&E Net |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
2
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
0
|
0
|
|
| Intangible Assets |
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
3
|
|
| Goodwill |
6
|
6
|
5
|
2
|
2
|
1
|
1
|
1
|
1
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
6
|
6
|
5
|
2
|
2
|
1
|
1
|
1
|
1
|
0
|
|
| Total Assets |
22
N/A
|
19
-12%
|
12
-41%
|
5
-57%
|
5
-6%
|
11
+126%
|
14
+36%
|
23
+61%
|
54
+134%
|
69
+29%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2
|
1
|
2
|
2
|
1
|
3
|
5
|
6
|
20
|
20
|
|
| Accrued Liabilities |
1
|
1
|
1
|
1
|
1
|
2
|
6
|
11
|
26
|
32
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
4
|
2
|
2
|
3
|
2
|
5
|
11
|
17
|
46
|
61
|
|
| Long-Term Debt |
0
|
0
|
1
|
1
|
1
|
3
|
1
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
8
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
4
N/A
|
10
+160%
|
3
-67%
|
5
+33%
|
3
-30%
|
8
+141%
|
12
+58%
|
17
+45%
|
46
+164%
|
61
+34%
|
|
| Equity | |||||||||||
| Common Stock |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
10
|
8
|
7
|
0
|
1
|
0
|
2
|
2
|
0
|
1
|
|
| Additional Paid In Capital |
8
|
0
|
0
|
0
|
0
|
2
|
4
|
7
|
8
|
9
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
18
N/A
|
9
-50%
|
8
-11%
|
0
-94%
|
1
+222%
|
3
+95%
|
2
-21%
|
6
+147%
|
8
+44%
|
8
+1%
|
|
| Total Liabilities & Equity |
22
N/A
|
19
-12%
|
12
-41%
|
5
-57%
|
5
-6%
|
11
+126%
|
14
+36%
|
23
+61%
|
54
+134%
|
69
+29%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
4
|
4
|
4
|
4
|
4
|
4
|
5
|
6
|
6
|
6
|
|